(Q39441712)

12 September 2017

1 reference

title

Drug treatment of asthma in the 1990s: achievements and new strategies (English)

1 reference

12 September 2017

0 references

Tavakkoli A

1

1 reference

12 September 2017

Rees PJ

series ordinal

2

1 reference

12 September 2017

publication date

1 January 1999

1 reference

12 September 2017

1 reference

12 September 2017

volume

57

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

1-8

1 reference

Worldwide trends in asthma mortality

12 September 2017

cites work

1 reference

12 December 2020

1 reference

12 December 2020

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

12 December 2020

The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air

1 reference

12 December 2020

Rapid Onset of Tolerance to the Bronchoprotective Effect of Salmeterol

1 reference

12 December 2020

Treatment of steroid-dependent bronchial asthma with cyclosporin

1 reference

12 December 2020

Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma

1 reference

12 December 2020

Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials

1 reference

12 December 2020

End of the New Zealand asthma mortality epidemic

1 reference

12 December 2020

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma

1 reference

12 December 2020

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

12 December 2020

Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma

1 reference

12 December 2020

Leukotrienes and aspirin induced asthma

1 reference

12 December 2020

Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep.

1 reference

12 December 2020

Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma

1 reference

12 December 2020

Is immunotherapy for asthma worthwhile?

1 reference

12 December 2020

Trial of a “credit card” asthma self-management plan in a high-risk group of patients with asthma

1 reference

12 December 2020

Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor

1 reference

12 December 2020

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

12 December 2020

Methotrexate in the treatment of systemic glucocorticoid-dependent severe persistent asthma: a word of caution

1 reference

12 December 2020

Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate

1 reference

12 December 2020

Mechanisms of action of glucocorticoids in asthma

1 reference

12 December 2020

Corticosteroid-resistant asthma. Definitions

1 reference

12 December 2020

The use of continuous quality improvement methods to implement practice guidelines in asthma

1 reference

12 December 2020

The inflammatory basis of asthma and its implications for drug treatment

1 reference

12 December 2020

Inhaled tryptase causes bronchoconstriction in sheep via histamine release

1 reference

12 December 2020

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

1 reference

12 December 2020

Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group

1 reference

12 December 2020

Leukotrienes in asthma. The potential therapeutic role of antileukotriene agents

1 reference

12 December 2020

Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma

1 reference

12 December 2020

Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group

1 reference

12 December 2020

Theophylline in chronic asthma--evidence for disease-modifying properties

1 reference

12 December 2020

The role of theophylline in the management of chronic asthma in adults

1 reference

12 December 2020

An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist

1 reference

12 December 2020

Salmeterol does not cause tolerance during long-term asthma therapy

1 reference

12 December 2020

A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study

1 reference

12 December 2020

Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma

1 reference

12 December 2020

The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control

1 reference

12 December 2020

NF-kappa B: a pivotal role in asthma and a new target for therapy

1 reference

12 December 2020

Role of tachykinins in bronchial hyper-responsiveness

1 reference

12 December 2020

The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects

1 reference

12 December 2020

Salmeterol versus theophylline in the treatment of asthma

1 reference

12 December 2020

Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study

1 reference

12 December 2020

Effect of cyclosporin A on the allergen-induced late asthmatic reaction

1 reference

12 December 2020

Anti-IgE therapy for asthma

1 reference

12 December 2020

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

1 reference

12 December 2020

Adoptive transfer of allergen-specific CD4+ T cells induces airway inflammation and hyperresponsiveness in Brown-Norway rats

1 reference

12 December 2020

Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses

1 reference

12 December 2020

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

12 December 2020

A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma

1 reference

12 December 2020

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents

1 reference

12 December 2020

Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients

1 reference

12 December 2020

Therapeutic potential of anti-IgE antibodies

1 reference

12 December 2020

Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma

1 reference

12 December 2020

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

1 reference

12 December 2020

10.2165/00003495-199957010-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

12 September 2017

1013105409

0 references

1 reference